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Abstract 
Objective: Depression is a highly common mental disorder and a major cause of disability worldwide. 
Several psychological interventions are available, but there is a lack of evidence to decide which 
treatment works best for whom. This study aimed to identify subgroups of patients who respond 
differentially to cognitive behavioural therapy (CBT) or person-centred counselling for depression 
(CfD). 
Methods: This was a retrospective analysis of archival routine practice data for 1435 patients who 
received either CBT (N=1104) or CfD (N=331) in primary care. The main outcome was post-treatment 
reliable and clinically significant improvement (RCSI) in the PHQ-9 depression measure. A targeted 
prescription algorithm was developed in a training sample (N=1085) using a supervised machine 
learning approach (elastic net with optimal scaling). The clinical utility of the algorithm was examined 
in a statistically independent test sample (N=350) using chi-square analysis and odds ratios. 
Results: Cases in the test sample that received their model-ŝŶĚŝĐĂƚĞĚ  “ŽƉƚŝŵĂů ? ƚƌĞĂƚŵĞŶƚ ŚĂĚ Ă
ƐŝŐŶŝĨŝĐĂŶƚůǇŚŝŐŚĞƌZ^/ƌĂƚĞ ? ? ? ? ?A? ?ĐŽŵƉĂƌĞĚƚŽƚŚŽƐĞǁŚŽƌĞĐĞŝǀĞĚƚŚĞ “ƐƵďŽƉƚŝŵĂů ?ƚƌĞĂƚŵĞŶƚ
(41.7%); x2 (DF = 1) = 4.79, p = .03, OR = 2.33 (95% CI = 1.09, 5.02). 
Conclusions: Targeted prescription has the potential to make best use of currently available evidence-
based treatments, improving outcomes for patients at no additional cost to psychological services. 
 
Keywords: depression; cognitive behavioural therapy; counselling; precision medicine; personalized 
treatment selection 
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Public health significance: Reviews of clinical trials often conclude that different types of 
psychological interventions for depression are equally efficacious, and differential effects are rarely 
statistically or clinically significant. Recent studies suggest that subgroups of patients with specific 
characteristics respond more favourably to specific psychotherapies, and therefore targeted 
prescription could potentially improve their treatment outcomes. Using data from a large (N=1435) 
naturalistic cohort of patients who accessed either cognitive behavioural therapy or person-centred 
counselling for depression, the present study found evidence of differential response to treatments 
in a subsample of ~30%. These results were cross-validated in an adequately powered external test 
sample, which considerably strengthens the reliability of findings. Targeted prescription of these 
widely available and well-established psychological treatments could potentially improve clinical 
outcomes at no additional cost to services, representing a major advance in precision mental 
healthcare. 
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1. Introduction 
Current guidelines for the management of depression in adults (National Institute for Health 
and Care Excellence; NICE, 2018) recommend psychological interventions such as cognitive 
behavioural therapy, interpersonal psychotherapy, brief psychodynamic therapy and person-centred 
counselling. These recommendations are informed by meta-analyses of randomized controlled trials 
which generally conclude that these psychological treatments are equally efficacious, and differential 
effects are rarely statistically or clinically significant (Cuijpers et al., 2008; Cuijpers et al., 2013). 
Practice-based studies comparing the effectiveness of psychological interventions reach similar 
conclusions. For example, a recent large-scale comparison of cognitive behavioural therapy (CBT) and 
person-centred counselling for depression (CfD) in primary care suggested that these treatments are 
equally effective (Pybis, Saxon, Hill, & Barkham, 2017).  
Evidence such as this has led some to argue that established therapies may work through 
similar mechanisms or so-called common factors (Frank and Frank 1991; Wampold and Imel, 2015), 
ƚŚƵƐũƵƐƚŝĨǇŝŶŐƚŚĞŶĞĞĚƚŽĐŽŶƐŝĚĞƌƉĂƚŝĞŶƚƐ ?ƉƌĞĨĞƌĞŶĐĞƐƚŚƌŽƵŐŚĂƐŚĂƌĞĚ-decision making process 
to guide treatment selection (Swift et al., 2011). Although there is evidence that accommodating 
ƉĂƚŝĞŶƚƐ ?ƚƌĞĂƚŵĞŶƚƉƌĞĨĞƌĞŶĐĞƐleads to better outcomes (Swift et al., 2018), there is ongoing debate 
in the field about the common factors and treatment equivalence hypotheses in psychotherapy 
(Mulder et al., 2017; Cuijpers et al., 2018). One line of argument is that different therapies may work 
better for different subgroups of patients with specific attributes, and that such aptitude-treatment 
interactions (ATI) are yet to be successfully identified (Cronbach and Snow, 1977). Despite its long 
history spanning over 40 years, ATI research has mostly yielded inconclusive evidence of differential 
treatment effects, possibly due to methodological problems including inadequately powered sample 
sizes, lack of replication in independent samples, and a predominance of studies investigating single 
variables as potential moderators of treatment effects (Dance and Neufeld, 1988; Smith and Sechrest, 
1991; Snow, 1991). 
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A renewed interest in ATI research is evident in the field of psychotherapy, spurred by the 
emergence of studies that apply a multivariable approach to investigate how to optimally match 
patients to treatments (Cohen and DeRubeis, 2018). Unlike traditional single-moderator studies, 
contemporary studies investigate the combined influence of multiple patient-attributes (e.g., 
demographic, diagnostic, personality features) to profile patients into subgroups that respond to 
treatment in similar ways. For example, multivariable prediction algorithms have been developed to 
identify patients who respond differentially to CBT vs. antidepressant medication (DeRubeis et al., 
2014), CBT vs. interpersonal psychotherapy (Huibers et al., 2015), CBT vs. eye-movement 
desensitization and reprocessing (Deisenhofer et al., 2018), prolonged exposure vs. cognitive 
processing therapy (Keefe et al., 2018), and CBT vs. psychodynamic therapy (Cohen et al., 2019). 
Recent studies are also leveraging the advantages of machine learning methods in order to optimize 
feature selection, to discover nonlinear associations and interactions between variables, and to yield 
prediction models that are more likely to generalise to new samples (e.g., Cohen et al., 2019; 
Deisenhofer et al., 2018; Delgadillo, Huey, Bennett, & McMillan, 2017; Keefe et al., 2018; Lorenzo-
Luaces et al., 2017). Despite the increased sophistication of new studies, this emerging literature is 
still limited by old problems. Most of these studies use samples from randomized controlled trials, 
which are often statistically underpowered for multivariable analyses. It is also likely that some studies 
that seek to discover so-called prescriptive variables (treatment x moderator interactions) are likely 
to be underpowered to achieve this and may well be treating spurious findings as clinically informative 
(Luedtke et al., 2019). Furthermore, in spite of their use of internal cross-validation procedures, the 
majority of these studies are limited by a lack of replication of the apparent advantage of personalized 
treatment selection in an adequately powered external (hold-out) test sample that was not used to 
train the prediction algorithms. These limitations mean that the generalisability, replicability and 
clinical value of emerging treatment selection algorithms are yet to be demonstrated. For these 
reasons, it has been suggested that large practice-based and observational datasets could help to 
overcome some of the limitations concerning sample size and might have the additional advantage of 
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yielding treatment selection models that generalise to ordinary healthcare populations (Kessler, 
Bossarte, Luedtke, Zaslavsky, & Zubizarreta, 2019). 
Informed by contemporary ATI research, the present study used a large practice-based 
dataset to investigate if certain subgroups of patients might respond differentially to CBT or CfD for 
depression. Based on prior studies, we hypothesised that a subsample of cases would show 
differential response to these treatments, and that cases assigned to their optimal treatment would 
have significantly higher rates of depression symptom remission. In order to support this hypothesis, 
the advantage of assignment to an optimal treatment would have to be replicated in an external 
validation sample which was not used to train the targeted prescription model. 
 
2. Method 
2.1. Setting and interventions 
This study is based on the analysis of fully anonymized routine care data from patients treated 
for depression in a primary care service in the North of England. The study was registered with the 
National Health Service as a service evaluation (Reference: SEP_0517a), and was exempt from 
research ethical approval.  
The participating service was part of the Improving Access to Psychological Therapies (IAPT) 
programme, a national treatment system which offers psychological interventions following a stepped 
care model (Clark, 2018). The initial step of treatment in this system involves brief (<8 sessions) guided 
self-help interventions offered to patients with mild-to-moderate symptoms. Patients who remain 
symptomatic after accessing guided self-help, or those deemed to be more severe cases at initial 
assessments, are stepped-up to high intensity therapies. All cases included in the present study sample 
accessed high intensity therapies, either CBT or CfD, which were prescribed using a shared-decision 
making process following clinical guidelines (NICE, 2018). This process typically requires the assessing 
clinician to provide a brief description to the patient regarding available treatments recommended for 
depression, after which an agreement is reached about a suitable treatment option. Such decisions 
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were often influenced by ƚŚĞĂƐƐĞƐƐŽƌ ?Ɛclinical judgment, consultation with other clinicians in the 
service, ƉĂƚŝĞŶƚƐ ?ƉƌĞĨĞƌĞŶĐĞƐ ?ĂŶĚĐŽŶƚĞǆƚƵĂůĨĂĐƚŽƌƐƐƵĐŚĂƐǁĂŝƚŝŶŐƚŝŵĞƐ ? 
  High intensity CBT in this service involved highly standardised, disorder-specific interventions 
listed in the Roth and Pilling (2008) competency framework. Patients with depression received 
protocol-driven Beckian CBT (Beck et al., 1979) or Behavioural Activation (Martell et al., 2001). The 
present study sample only selected cases that accessed Beckian CBT with accredited therapists, whose 
training was based on a national curriculum (Department of Health, 2011). CfD for depression is a 
person-centred, non-directive, experiential form of theƌĂƉǇ ďƌŽĂĚůǇ ĂůŝŐŶĞĚ ƚŽ ZŽŐĞƌƐ ? ƐĐŚŽŽů ŽĨ
humanistic counselling (Sanders and Hill, 2014). CfD was delivered by accredited counsellors who 
completed a counselling for depression training course guided by a national curriculum (Hill, 2011a) 
and competency framework (Hill, 2011b).  
According to national guidelines, patients should access up to 20 sessions of CBT or up to 12 
sessions of CfD (NICE, 2018). In practice, the mean number of sessions accessed by CBT (M=9.56, 
SD=7.02) and CfD cases (M=8.31, SD=4.29) in the study sample was not significantly different; Mann-
Whitney U = 175647.00, p = .29. All therapists (CBT, CfD) in the service practiced under regular (weekly 
or every two-weeks) clinical supervision with accredited and experienced supervisors specialising in 
their treatment modality. 
2.2. Measures 
The primary outcome measure in this study was the Patient Health Questionnaire (PHQ-9; 
Kroenke, Spitzer, & Williams, 2001), which is a nine-item screening tool for depression. Each item is 
rated on a four-ƉŽŝŶƚ>ŝŬĞƌƚƐĐĂůĞƌĂŶŐŝŶŐĨƌŽŵ “ ? ? ?ŶŽƚĂƚĂůů ?ƚŽ “ ? ? ?ŶĞĂƌůǇĞǀĞƌǇĚĂǇ ? ?dŽƚĂůƐĐŽƌĞƐ
range from 0 to 27, where lower scores indicate less severe symptoms. A cut-ŽĨĨ A? ? ? ŚĂƐ ďĞĞŶ
recommended identify clinically significant symptoms of major depressive disorder, with adequate 
sensitivity (88%) and specificity (88%) (Kroenke et al., 2001 ? ?  ĐŚĂŶŐĞ A? ? ƉŽŝŶƚƐ ŚĂƐ ďĞĞŶ
recommended to assess statistically reliable improvement or deterioration (Richards & Borglin, 2011).  
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Patients treated in the participating service completed the PHQ-9 at an initial (pre-treatment) 
assessment, and before each weekly therapy session.  In addition to the PHQ-9 measure, patients also 
completed weekly measures of anxiety symptoms (GAD-7; Spitzer, Kroenke, Williams, & Löwe, 2006) 
and functional impairment (WSAS; Mundt, Marks, Shear, & Greist, 2002) using standardised 
questionnaires. A last-observation-carried-forward method was programmed into the clinical service 
database, which prevented loss of data due to early treatment dropout and enabled an intention-to-
treat approach to data analysis. Only pre- and post-treatment outcome measures were included in 
the study dataset. 
At initial assessment, a standardised set of demographic and clinical information was gathered. 
Demographics included: gender, age, ethnicity, employment status and disability. The index of 
multiple deprivation (IMD) was also collected, which is an area-level index of socioeconomic 
ĚĞƉƌŝǀĂƚŝŽŶĨŽƌĞĂĐŚƉĂƚŝĞŶƚ ?ƐŶĞŝŐŚďŽƵƌŚŽŽĚ (Department for Communities and Local Government, 
2011). Clinical information included primary diagnosis, chronicity (duration in years/months) of the 
primary problem, number of previous treatment episodes, comorbidity of long-term conditions (e.g., 
diabetes, asthma, etc.), antidepressant medication status, and outcome expectancy using a 
standardised measure (Lutz, Leon, Martinovich, Lyons & Stiles, 2007).  
2.3. Sample characteristics 
The study sample (N = 1435) only included patients who ĂĐĐĞƐƐĞĚA? ?ƐĞƐƐŝŽŶƐ of high intensity 
CBT or CfD, who had a primary diagnosis of major depressive disorder or recurrent depression, and 
who had case-level symptoms at the first session of high intensity therapy (PHQ- ?A? ? ? ?. At least two 
sessions were necessary to take the first as a baseline measure, and the last attended session as a 
post-treatment measure. More patients accessed CBT (N = 1104) compared to CfD (N = 331), since 
there was a larger number of qualified CBT therapists (N = 67) compared to counsellors (N = 12). Less 
than half (40.6%) of patients had previously accessed low intensity guided self-help before being 
stepped-up to either CBT or CfD. The average duration of a treatment episode, from initial assessment 
to end of treatment, was 7.12 months (SD=4.40). 
  
 
9 
 
Table 1 presents a detailed summary of sample characteristics. Statistical comparisons 
between CBT and CfD cases revealed significant case-mix differences in demographic and clinical 
features, showing that CBT cases tended to have higher indices of symptom severity (PHQ-9, GAD-7), 
functional impairment (WSAS) and use of antidepressant medication. 
 
[Table 1] 
 
2.4. Data analysis 
The primary objective of the analysis was to develop an algorithm that would prescribe CBT 
vs. CfD based on the identification of subgroups of patients who tend to respond better to one or the 
other treatment. To achieve this, the analysis was conducted in four steps: (1) partitioning of the 
dataset into training and test samples; (2) development of prognostic indices for each form of 
treatment; (3) development of a treatment prescription algorithm; (4) external cross-validation of the 
algorithm in the test sample. 
 Our first challenge was to construct a test sample that (a) was adequately powered and (b) 
ďĂůĂŶĐĞĚƉĂƚŝĞŶƚƐ ?ĐŚĂƌĂĐƚĞƌŝƐƚŝĐƐĂĐƌŽƐƐŐƌŽƵƉƐŝŶĂƐŝŵŝůĂƌǁĂǇƚŽƌĂŶĚŽŵŝƐĞĚĞǆƉĞƌŝŵĞŶƚƐ ? so as to 
minimise confounding due to the natural selection of cases into CBT or CfD through shared decision-
making. ƐĂŵƉůĞƐŝǌĞĐĂůĐƵůĂƚŝŽŶďĂƐĞĚŽŶŽŚĞŶ ?Ɛrule (1992) indicated that 87 cases were required 
to detect a medium effect size comparing cases that received their optimal vs. suboptimal treatment, 
using a chi-square analysis with DF = 1, ɲA? ? ? ?ĂŶĚ ? ?A?ƉŽǁĞƌ ? Informed by recent studies focusing 
on depression (DeRubeis et al., 2014, Cohen et al., 2019), we expected that only a subgroup of cases 
would be classified as having an optimal treatment. Therefore, we quadrupled the sample size 
requirement (N = 350) to ensure the sample would be sufficient to carry out hypothesis testing in a 
subset of cases as small as 25%. The sample size calculation was carried out specifically to undertake 
one primary hypothesis test in an external validation sample, and to avoid multiple tests in the same 
sample which is a common pitfall and limitation in prior treatment selection studies. 
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On this basis, we selected a random sample of 175 CBT cases from the full dataset and 
matched them to 175 CfD cases using propensity score matching (Rosenbaum & Rubin, 1983). 
Propensity score matching is an appropriate statistical approach to balance baseline differences in 
observed covariates across groups of patients exposed to different treatments in observational 
studies (Rosenbaum, 2017), and is recommended to support the development of treatment selection 
rules using naturalistic datasets (Kessler et al., 2019). This matching procedure was based on a logistic 
regression predicting CBT group membership, entering all demographic and pre-treatment clinical 
measures described in Table 1 as predictors, using a one-to-one nearest neighbours approach with a 
conservative tolerance level (calliper = 0.2) specified a priori, and allowing replacement to maximize 
matching precision. This procedure resulted in a test sample of 350 cases with balanced characteristics 
across groups (shown in online supplemental material), and a larger training sample of 1085 cases. 
In the second step, each case in the full dataset was labelled with a binary clinical outcome 
(RCSI = 0 or 1) applying conventional criteria for reliable and clinically significant improvement 
(Jacobson and Truax, 1991), which participating therapists used to assess depression treatment 
response in routine care. RCSI was attained if post-treatment PHQ-9 scores were below the diagnostic 
cut-ŽĨĨ  ?A? ? ? ? ĂŶĚ A? ? ƉŽŝŶƚƐ ůŽǁĞƌ ƚŚĂŶ ƚŚĞ W,Y-9 measure at the first session of high intensity 
treatment. Missing data (< 10% in this sample) for demographic and clinical features were imputed 
using an expectation-maximization method (Schafer & Olsden, 1998).  
Next, prognostic indices for each treatment were developed by separately analysing CBT (N = 
929) and CfD (N = 156) cases in the training sample (N = 1085), enabling the identification of common 
and unique predictors for two alternative treatments. The prognostic index was expressed as a 
predicted probability of attaining post-treatment RCSI, based on the combined weight of multiple 
patient-characteristics that were available before the start of treatment. Variable selection and weight 
setting to construct each prognostic index were performed using a supervised machine learning 
approach, with the RCSI label as a dependent variable. This statistical model combined Elastic Net 
regularization, optimal scaling, and nested internal cross-validation loops. Elastic Net regularization 
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combines the Ridge regression and LASSO approaches, which are part of the penalized regression 
family of machine learning algorithms developed to enhance prediction accuracy and generalizability 
(Zou & Hastie, 2005). Ridge regression minimizes the residual sum of squares through the application 
of L2 regularization, imposing the  “sum of squared values of all coefficients ?ĂƐa penalty term that 
shrinks coefficients towards zero to minimize overfitting to a training sample. This shrinkage 
procedure differentially weights variables according to their predictive importance, allowing multiple 
and inter-correlated variables in the same model. The LASSO (Least Absolute Shrinkage and Selection 
Operator) applies L1 regularization, imposing the  “sum of absolute values of all coefficients ? as a 
penalty term that shrinks coefficients exactly to zero if they have no predictive value or if they are 
highly collinear with stronger predictors in the model. As such, the LASSO additionally performs 
feature selection by shrinking some coefficients to zero, yielding sparse and conservative models 
(Tibshirani, 1996). The Elastic Net approach leverages the advantages of both L1 and L2 regularization, 
ĂƚƚĂŝŶŝŶŐĨĞĂƚƵƌĞƐĞůĞĐƚŝŽŶǀŝĂƚŚĞ>^^KĂŶĚĂůůŽǁŝŶŐĨŽƌƚŚĞŝŶĐůƵƐŝŽŶŽĨ “ǁĞĂŬƉƌĞĚŝĐƚŽƌƐ ?ǀŝĂZŝĚŐĞ
regression in a model that is robust to multicollinearity. Optimal scaling enables the discovery of non-
linear relationships between dependent and independent variables by fitting splines (Gifi, 1990). An 
advantage of optimal scaling is that it enables the discovery of non-linear trends that are not pre-
specified, without a need to introduce (or penalize) exponential terms (e.g., quadratic, cubic) into the 
model. In order to determine the model with minimum expected prediction error, an internal cross-
validation loop was applied 1000 times to each iteration of the Elastic Net solution increasing the 
penalty terms in 0.01 units (also known as a grid search), using the .632+ bootstrap resampling method 
(Efron & Tibshirani, 1997). The optimal model was chosen using the 1 standard error rule. The grid 
search space was constrained by the alpha hyperparameter  ?ɲ= 0.10), which was found to optimize 
predictive accuracy with this set of features, in parameter tuning tests run within the training sample. 
As recommended by previous researchers, we ran a minimal number of parameter tuning tests to 
minimize overfitting due to multiple testing (Pearson, Pisner, Meyer, Shumake, & Beevers, 2018), 
comparing three alpha values selected a priori:  ɲA? ? ? ? ? ?ɲA? ? ? ? ? ?ɲA? ? ? ? ? ?The resulting treatment-
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specific equations could be applied to new cases (whose demographic and clinical features are known) 
in order to calculate the predicted probability of symptom remission (RCSI) with CBT or with CfD. 
In order to test the robustness of the above prognostic model, we also generated an aptitude-
treatment-interaction (ATI) model using the full training sample pooling CBT and CfD cases. To achieve 
this, we trained an ensemble of 1000 decision trees using a random forest approach (Breiman, 2001) 
which yielded predicted probabilities of response to CBT and CfD for each patient based on their 
individual features.1 We examined the accuracy of the prognostic versus ATI models in the test sample 
(N = 350), comparing the predicted probabilities yielded by each model using the area under the curve 
(AUC). The most accurate model was then used to develop a targeted prescription algorithm described 
below. 
In the third step of analysis, we used the optimal equations constructed in the training sample 
to develop a personalized advantage index (PAI; DeRubeis et al., 2014). The PAI was calculated by 
taking the difference between the two prognostic indices (CBT prognosis  ? CfD prognosis) for each 
case. It was expressed in percentage (probability) units and was centred at zero; where a positive 
score favoured prescribing CBT and a negative score favoured CfD. We then classified cases into three 
subgroups based on the PAI cut-offs that were found to be 1 standard deviation above/below the 
mean: cases for whom no optimal treatment was strongly indicated (PAI close to the mean), and cases 
for whom the (model-indicated) optimal prescription was CBT or CfD. 
In the final step of analysis, we performed chi-square analyses and estimated odds ratios to 
compare observed RCSI rates between cases in the test sample that received their (model-indicated) 
optimal treatment vs. cases that received the suboptimal treatment. A series of sensitivity analyses 
were performed to assess the robustness of these results; adjusting the odds ratios after controlling 
for (a) prior low intensity treatment and (b) propensity scores. We calculated a mean prognostic index 
(MPI; mean of the two treatment-specific prognoses) for each case in the test sample, and examined 
                                                 
1 Further details about this analytic approach are provided in supplementary appendix A. 
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its correlation with the PAI. Finally, in order to assess if the primary results were not simply an artefact 
of the RCSI binary outcome metric, we compared differences in post-treatment PHQ-9 scores between 
cases assigned to optimal vs. suboptimal treatments using effect sizes (Hedges ? g, adjusting for small 
and unbalanced sample sizes). 
 
3. Results 
3.1. General effectiveness of therapy 
The base rate of cases meeting RCSI criteria in the full sample was 40.2%, with no significant 
differences between the CBT (39.3%) and CfD (43.2%) groups; x2 (DF = 1) = 1.60, p = .21. 
 
[Table 2] 
 
3.2. Comparison of prognostic vs. ATI models 
 Table 2 compares the relative performance of alternative outcome prediction models in the 
training and test samples. Overall, the performance of the prognostic model was more stable (lower 
cross-validation shrinkage) and marginally better than the ATI model in the test sample (average AUC 
0.62 vs. 0.58). Therefore, subsequent analyses applied the prognostic model equations. 
 
[Table 3] 
 
3.3. Predictors of treatment outcomes 
Table 2 shows the variables and regularized coefficients selected into the optimal prognostic 
models for each treatment group. Beta coefficients that were shrunk to exactly 0 were indicative of 
variables that did not have prognostic value. Six common prognostic variables featured in both 
prediction models: age, employment status, disability, baseline PHQ-9 and WSAS, and IMD. Disability 
predicted poorer outcomes in CBT but better outcomes in CfD. Patients living in more deprived areas 
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tended to have poor outcomes in CBT, but better outcomes in CfD. Ethnicity was only relevant to CBT, 
where people from minority ethnic groups tended to have poorer outcomes. Four variables were only 
relevant to CfD: better treatment outcomes were predicted for patients with higher baseline anxiety, 
longer chronicity, lower outcome expectancy and those not taking antidepressant medication. The 
relative magnitude of regularized coefficients provides an indication of the prognostic importance of 
each variable.2  Baseline depression severity (PHQ-9) was the most important predictor for CBT, 
whereas baseline functional impairment (WSAS) was most important for CfD. 
 
[Figure 1] 
 
3.4. External cross-validation of targeted prescription model 
Using PAI scores derived from the above prognostic models enabled us to classify test-sample 
cases into three groups: those for whom no optimal treatment was selected (N = 238, 68.0%), and 
those for whom the optimal treatment was CBT (N = 48, 13.7%) or CfD (N = 64, 18.3%). Within the 
subset of cases that had differential response to treatment, 57.1% did in fact receive their optimal 
treatment, although agreement between the model-indicated prescription and the actual prescription 
was weak (Kappa = .13, SE = .09). Figure 1 shows that cases that received their model-indicated 
treatment had a significantly higher RCSI rate (62.5%) compared to those who received the suboptimal 
treatment (41.7%); x2 (DF = 1) = 4.79, p = .03; OR = 2.33 (95% CI = 1.09, 5.02), Nagelkerke R2 = .06. 
These findings were robust to sensitivity analyses. The odds ratios remained statistically significant (p 
< .05) after controlling for prior low intensity treatment in the stepped care system (OR = 2.31 [95% 
CI = 1.08, 4.98]) and after controlling for propensity scores (OR = 2.18 [95% CI = 1.01, 4.74]). 
 
[Figure 2] 
                                                 
2 For comparison, a predictor importance chart for the random forest approach is available in supplemental appendix B. 
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 Figure 2 plots the distribution of PAI scores against MPI scores, which were moderately 
correlated; r = -.35, p <.001. The most responsive cases (MPI >60%, less severe and complex cases) 
tended to have a model-indicated advantage in CfD; whereas the least responsive cases (MPI <20%) 
tended to have no model-indicated treatment. 
Figure 3 presents between-group effect sizes for cases in the test sample that were assigned 
to their optimal vs. suboptimal treatment. The overall effect size was g = .26, favouring assignment to 
the optimal treatment. We examined effect sizes for subsamples that excluded cases with the best 
and poorest expected prognoses along the MPI scale. Mean post-treatment PHQ-9 scores were 
consistently lower in cases assigned to their optimal treatment across all subgroups (see online 
supplement). However, as shown in Figure 3, optimal treatment assignment resulted in a greater 
advantage (g = .41) for cases in the middle range of the MPI scale. 
 
[Figure 3] 
 
4. Discussion 
4.1. Main findings 
Consistent with previous studies (e.g., Pybis et al., 2017), we found no significant differences 
in treatment outcomes when results were aggregated and broadly compared between CBT and CfD. 
However, using a machine learning analysis and external cross-validation procedure, we identified a 
subgroup of patients (~30%) with differential response to these treatments. Within this subgroup, 
patients who accessed their model-indicated treatment had significantly higher response rates (~60%) 
compared to those who received the suboptimal treatment (~40%). The odds ratio for this comparison 
(2.33) indicates that patients assigned to their optimal treatment were 2 times more likely to attain 
reliable and clinically significant improvement. This finding remained significant after controlling for 
cases that accessed prior low intensity treatment (41%), which was not associated with response rates. 
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The main result was also robust to sensitivity analyses adjusting for the non-random assignment of 
cases to treatments, and examining between-group differences in post-treatment PHQ-9 scores. 
4.2. Implications for practice and theory 
We found that the shared decision-making process which guided treatment selection in this 
service tended to prescribe treatments appropriately for only 57% of cases where targeted 
prescription really matters. Clearly, treatment outcomes could be improved if more patients within 
this subgroup were consistently matched to their optimal treatment. The most responsive and less 
impaired cases (MPI > .60) tended to be better candidates for CfD. Moreover, no optimal treatment 
was indicated for the subgroup of cases who had extremely poor expected prognoses (MPI < .10). This 
observation is consistent with the intractable cases hypothesis (DeRubeis et al., 2014b), which 
suggests that no differential treatment response would be found in the cases that are most difficult 
to treat. 
These findings challenge the assumption of treatment equivalence, since evidently some 
patients respond better to CBT and others to CfD. It is also difficult to reconcile these findings with the 
common factors model (Wampold & Imel, 2015). If CBT and CfD worked through the same 
mechanisms of action, no differential response would be observed in cases that are equally responsive 
to treatment (e.g., cases close to the mean of the MPI distribution, who in fact benefited the most 
from optimal treatment assignment). Furthermore, patients in this cohort accessed treatment based 
on shared decision-ŵĂŬŝŶŐ ?ǁŚŝĐŚĐŽŶƐŝĚĞƌƐƉĂƚŝĞŶƚƐ ?ƉƌĞĨĞƌĞŶĐĞƐ (NICE, 2018). Even after controlling 
for this allocation process (using propensity scores), differential treatment effects were still observed, 
so this cannot be simply explained by preference accommodation (Swift et al., 2018).  
We identified several variables that predict differential effects in each treatment, and which 
could be thought of as moderators. Patients from minority ethnic groups, living in poverty, and with 
disabilities tended to have a poorer response to CBT, whereas they tended to have better outcomes 
in CfD. There is a growing literature on the need for cultural adaptation of CBT to enhance its 
acceptability to minority ethnic populations (e.g., Hinton, Rivera, Hofmann, Barlow, & Otto, 2012; 
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Naeem, Waheed, Gobbi, Ayub, & Kingdon, 2011). Emerging evidence also suggests that psychological 
treatments such as CBT might not be adequately meeting the needs of patients from 
socioeconomically deprived backgrounds (see review by Finegan, Firth, Wojnarowski, & Delgadillo, 
2018), and may thus require some adaptation. On the other hand, CfD was less effective for patients 
who had a shorter chronicity of depression, high outcome expectations, and who were taking 
antidepressant medications. It may be that such cases have a greater degree of self-efficacy and 
readiness to change, and benefit from a change-oriented and skills-based intervention like CBT. 
Although our interpretations of the findings are speculative in the absence of therapy process data, it 
is plausible that CBT and CfD have specific mechanisms of action (over and above common factors) 
that are necessary to attain remission of symptoms in subgroups of cases with specific characteristics: 
a phenotype-mechanism match. Alternatively, it might be that these treatments do not work well in 
patients with certain characteristics, and targeted prescription might actually rectify a phenotype-
treatment mismatch. Limitations of the present data preclude us from drawing firm conclusions about 
the explanation for the observed differential effects; but future research may help to elucidate if this 
may be due to phenotype-mechanism match, phenotype-treatment mismatch, or both. 
4.3. Methodological considerations 
Overall, our findings concur with recent studies showing differential treatment effects when 
comparing different psychotherapies for depression (Huibers et al., 2015; Cohen et al., 2019). Unlike 
most prior studies, the present results were cross-validated in an external test sample that was not 
used to train the prediction model. In addition, the sample was adequately powered for the intended 
analyses, using a robust method to identify common and unique prognostic indicators for each 
treatment. There is a current debate in this field about alternative approaches to develop treatment 
selection models (e.g., prognostic models vs. ATI models) and to select and weight variables for such 
models. In this study, we have shown that developing regularized prognostic indices separately for 
each treatment sample yielded more stable and accurate predictions compared to an ATI model 
trained using a random forest approach. Furthermore, we found that the cross-validation shrinkage 
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of the ATI model was large (~ 0.29 training-to-test AUC difference), which is indicative of considerable 
overfitting in the training sample. The prognostic model is likely to be less vulnerable to selecting 
spurious prescriptive variables, compared to ATI approaches that attempt to model interactions in 
relatively small samples such as the CfD group in this study (<200 cases). These features of the study 
sample and design increase our confidence in the generalisability of these findings, although there are 
also several caveats and methodological limitations that should be considered.  
Firstly, the reliance on routine practice data raises problems with internal validity, since 
treatment allocation was not randomised. We applied appropriate methods to adjust for non-random 
allocation (propensity score matching, and adjustment for propensity scores), although these 
methods also have limitations and do not rule out the possibility that relevant unmeasured factors 
may not be balanced across groups (Smith & Todd, 2005). Other rigorous causal inference methods 
for observational samples are available, such as G-computation (Snowden, Rose, & Mortimer, 2011) 
or targeted maximum likelihood estimation (Schuler & Rose, 2017), which may yield different results 
and could be examined in combination with machine learning analyses in future studies. On the other 
hand, the naturalistic study design enhances external validity, particularly since the treatments were 
highly standardised, closely supervised, and consistent with routine practice in IAPT stepped care 
services. Still, the dataset was drawn from a single service, and the extent to which this targeted 
prescription model may generalize to other services and groups of therapists is unknown.  
We note that the accuracy of treatment-specific prognostic indices was modest (test-sample 
AUC = 0.59 to 0.65) by conventional standards. The AUC statistic is commonly used in diagnostic 
accuracy studies to assess the performance of a screening test relative to a diagnostic standard, where 
values above 0.70 are deemed clinically useful (Swets, 1988). Large AUC values are to be expected in 
diagnostic accuracy studies that measure the test (predictor) and diagnostic standard (outcome) 
contiguously in time (i.e., on the same day). From a signal detection perspective, we might say that a 
valid screening test is measuring a proximal outcome: an underlying condition which is present at the 
time of screening. However, the prognostic models detailed above are in fact predicting distal 
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outcomes that occur approximately 7 months after initial (pre-treatment) assessments. From this 
viewpoint, it is remarkable that a relatively sparse set of features gathered before the start of 
treatment can yield clinically useful prognostic models which generalize to a new sample, and which 
could potentially double the probability of improvement for patients who are likely to benefit from 
targeted prescription. The above AUC values, therefore, should be interpreted as small-to-moderate 
effect sizes for the prediction of distal outcomes (approximate CoheŶ ?Ɛd = .32 to .54). These data-
driven methods are imperfect, but they still represent a considerable advance over the well-known 
limitations of prognostic assessments derived from clinical judgment (Ægisdóttir et al., 2006). 
Another caveat is that we chose to apply a binary outcome (RCSI) rather than a continuous 
outcome measure (e.g., post-treatment PHQ-9) in our main analyses. Loss of power and information 
can be a disadvantage of dichotomizing continuous measures. As explained above, we have taken 
great care to work out a sample size calculation for a binary outcome, and to construct a test sample 
that would be adequately powered, using highly conservative assumptions (expecting to detect a 
medium effect in a subgroup as small as 25% of the sample). Any costs in terms of statistical loss of 
information are outweighed by the fact that the RCSI definition gives us a better grasp of individualised 
outcomes, since we can count and estimate the proportion of individuals who attained full remission 
of symptoms. As shown in Figure 3, assessing outcomes using aggregated mean differences between 
groups obscures the fact that some cases benefit more from optimal treatment assignment compared 
to others. In addition, the RCSI definition is routinely applied to assess treatment response in the 
target services that could implement this treatment selection algorithm, and it is also highly cited and 
applied in the psychotherapy literature (Jacobson & Truax, 1991). Furthermore, this stringent 
outcome definition prioritizes the attainment of remission of symptoms to maximize maintenance of 
treatment gains, rather than simply a reduction of symptomology, and is consistent with evidence 
that partial remission of depression symptoms is a well-known risk factor for short-term relapse 
(Paykel, 2008; Wojnarowski, Firth, Finegan, & Delgadillo, 2019). Another reason to apply a binary 
outcome definition that prioritises remission of symptoms is to overcome classification problems that 
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can occur when developing treatment selection algorithms using a continuous outcome measure. For 
example, a PAI model based on predicted post-treatment scores could classify  “treatment A ? as 
optimal even if no significant change is expected, but if  “treatment B ? is expected to result in 
deterioration. Similarly, in a scenario where deterioration is predicted in both treatments, the 
treatment with the least expected deterioration could be selected as optimal. Such recommendations 
would be unacceptable in clinical practice, especially in the context of a stepped care system where 
other intensive treatment options could be offered if little progress is expected with first-line 
psychological treatments. The algorithms that we produced would enable clinicians to determine 
which of these two treatment options may be advantageous for specific individuals, but also to 
estimate a general expected prognosis, which might in fact help to fast-track some cases to other 
more intensive treatments. 
On balance, the evidence outlined in this study makes a persuasive case to move towards 
testing the efficacy of targeted prescription in prospective, experimental studies. At worst, this would 
be no different than the current shared decision-making strategy, with minimal associated risks. 
However, if the potential benefits of targeted prescription are demonstrated in an adequately 
powered controlled trial, this could represent a major advance in our ability to make best use of 
currently available evidence-based treatments, improving outcomes for patients at no additional cost 
to psychological services. 
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Table 1. Sample characteristics and comparisons between therapy groups 
 
 
CBT = cognitive-behavioural therapy; CfD = Counselling for Depression; IMD Decile = Index of multiple deprivation in deciles; 
PHQ-9 = Patient Health Questionnaire; GAD-7 = Generalized Anxiety Disorder Questionnaire; WSAS = Work and Social 
Adjustment Scale 
1 = Mean and Standard Deviation; 2 = Percentages 
 
 
  
 Full sample CBT CfD 
test statistic p 
 
N = 1435 
(100%) 
N = 1104 
(76.93%) 
N = 331 
(23.07%) 
Demographics 
Females 2 64.4% 63.2% 68.3% x2 (1)=2.84  .092 
Age 1 39.64 (12.87) 39.18 (12.73)  41.19 (13.23) t (1,433)=-2.49 .013 
Ethnicity 2      
       White British 88.2% 87.9% 89.4% x2 (1)=0.60  .439 
       Other 11.8% 12.1% 10.6%   
IMD decile 1      
       1 = Poorest 
      10 = Affluent 
4.51 (2.91)  4.51 (2.91) 4.53 (2.91) t (1,433)=-0.12  .906 
Unemployed 2 29.5% 31.4% 23.3% x2 (1)=8.16 .004 
Disabled 2 16.9% 16.4% 18.7% x2 (1)=0.99 .320 
Baseline severity measures 
PHQ-9 1 17.50 (4.50) 17.67 (4.57) 16.94 (4.25) t (1433)=2.59  .010 
GAD-7 1 13.79 (4.53) 13.92 (4.56) 13.34 (4.40) t (1433)=2.07  .038 
WSAS 1 22.81 (7.97) 23.42 (7.93) 20.79 (7.74) t (1433)=5.32  <.001 
Diagnosis 2 
       Depressive Episode 
       Recurrent Depression 
 
74.9% 
25.1% 
 
71.5% 
28.5% 
 
86.4% 
13.6% 
 
x2 (1)=30.23 
 
<.001 
Long term condition2 26.8% 25.3% 32.0% x2 (1)=5.92 .015 
Chronicity (deciles) 1  5.48 (2.94) 5.63 (3.00) 4.98 (2.71) t (593)=3.71  <.001 
Expectancy 1  7.13 (1.82) 7.08 (1.84) 7.28 (1.79) t (1433)=-1.75  .080 
Previous treatment 2 72.8% 73.8% 69.5% x2 (1)=2.42 .120 
Taking medication 2 65.6% 68.0% 57.4% x2 (1)= 12.73 <.001 
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Table 2. Predictive accuracy of prognostic model vs. aptitude-treatment-interaction (ATI) model 
 
 Training 
sample 
 Test  
sample 
 Cross-validation  
shrinkage 
 AUC  AUC  AUC difference 
Prognostic model trained using elastic net with optimal scaling 
CBT outcomes .67  .59  .08 
CfD outcomes .71  .65  .06 
ATI model trained using a random forest ensemble of 1000 decision trees 
CBT outcomes .86  .58  .28 
CfD outcomes .87  .57  .30 
Notes: CBT = cognitive behavioural therapy; CfD = Person-centred counselling for depression; 
outcomes = post-treatment reliable and clinically significant improvement in depression 
symptoms measured using the PHQ-9 questionnaire; AUC = area under the curve; cross-
validation shrinkage = an index of cross-validation performance, where lower values are 
indicative of more stable predictions and adequate generalization to an external test sample 
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Table 3. Elastic Net: variable selection and regularized coefficients for each prognostic model 
 
 CBT training sample (N=929)  
R-square = .09 
 CFD training sample (N=156)  
R-square = .13 
Variables B SE  B SE 
Gender .000 .011  .000 .040 
Age decade* .010 .026  .065 .048 
Minority ethnic group1 -.002 .019  .000 .032 
Unemployed* -.078 .031  -.045 .062 
Disability* -.051 .028  .036 .063 
Recurrent depression .000 .009  .000 .038 
Comorbid long-term condition .000 .017  .000 .042 
Previous treatment .000 .007  .000 .038 
ADM2 .000 .010  -.109 .072 
Baseline PHQ-9* -.166 .036  -.054 .133 
Baseline GAD-72 .000 .026  .004 .087 
Baseline WSAS* -.025 .027  -.158 .079 
IMD decile* .010 .024  -.026 .081 
Chronicity decile2 .000 .016  .025 .104 
Expectancy2 .000 .018  -.039 .071 
CBT = cognitive behavioural therapy; CFD = person-centred counselling; * Variables that had prognostic value for both CBT and CFD 
treatments; 1 variables that only predicted CBT outcomes; 2 variables that only predicted CFD outcomes; Gender reference category = 
male; Age was categorized into decade groups; Minority ethnic group reference category = white British; Recurrent depression diagnosis 
reference category = major depressive disorder; ADM = taking antidepressant medication; all baseline scores were taken before the start 
of the first high intensity therapy session; IMD = index of multiple deprivation, where higher values indicate more affluent (less deprived) 
neighbourhoods; chronicity = duration of primary diagnosis 
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Figure 1. Cross-validation of targeted prescription model in an external test sample 
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Figure 2. Distribution of personalized advantage index scores according to expected prognosis 
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Figure 3. Between-ŐƌŽƵƉĞĨĨĞĐƚƐŝǌĞƐ ?,ĞĚŐĞƐ ?Ő ?ĨŽƌŽƉƚŝŵĂůǀƐ ?ƐƵďŽƉƚŝŵĂůƚƌĞĂƚŵĞŶƚĂƐƐŝŐŶŵĞŶƚĂůŽŶŐƚŚĞDW/ŐƌĂĚŝĞŶƚ 
 
